Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue

NCT00003273 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00003273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 1997
Completion date
Not reported
Enrollment
0 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, neuroblastoma, retinoblastoma, sarcoma